Michael D'Amato, Director at Evolent Health, Inc. (EVH), bought 15,000 shares at $7.03 ($105K) on 2019-08-09, disclosed to the SEC on 2019-08-13.
Open-market purchase of $105k EVH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| EVH | BUY | 2016-11-16 | $172K | — | Filing → |